🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)

Found 14 matching trials

Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy

This study evaluates whether adding a spacer device to triple inhaled thera...

Status

Recruiting

Location

The Second Affiliated Hospital of Anhui Medical University

Start Date

2025-06-17

Trial ID

NCT07030881

Treatments Being Tested

pMDI Triple Inhaler and Spacer pMDI Triple Inhaler Only

Systematic Approach for the Diagnosis and Treatment of Obstructive Lung Diseases

N/A

The differential diagnosis of asthma and COPD is sometimes difficult. Recen...

Status

Unknown

Location

UZ Gasthuisberg

Start Date

2015-07

Trial ID

NCT02488590

Treatments Being Tested

LABA + LAMA ICS LABA + LAMA + ICS LABA + ICS other

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy

N/A

To assess the comparative effectiveness of combination Tiotropium and Oloda...

Status

Completed

Location

HealthCore, Inc.

Start Date

2019-11-01

Trial ID

NCT04184297

Treatments Being Tested

Tiotropium and Olodaterol (Tio+Olo)Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

PHASE4

The primary objective of this pragmatic study is to compare the time to fir...

Status

Completed

Location

Pulmonary Associates of Mobile, PC

Start Date

2017-09-20

Trial ID

NCT03265145

Treatments Being Tested

Stiolto Respimat ICS (Inhaled Corticosteroid) (Triple therapy)LABA (Long-Acting Beta Agonist) (Triple therapy)LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)

Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)

N/A

Open-label comparative multicentric cohort study in COPD patients with LABA...

Status

Completed

Location

Dr. Graubner

Start Date

2019-06-07

Trial ID

NCT03954132

Treatments Being Tested

Spiolto® Respimat®Triple-Therapy (LAMA/LABA/ICS)

Effectiveness of Triple Therapy in COPD

N/A

To assess the effectiveness of maintenance treatment of Chronic obstructive...

Status

Completed

Location

Clinical Practice Research Datalink

Start Date

2018-11-10

Trial ID

NCT03724877

Treatments Being Tested

Long-acting beta2-agonist-long-acting muscarinic antagonists-inhaled corticosteroids(LABA-LAMA-ICS)Long-acting beta2-agonist-inhaled corticosteroids-long-acting muscarinic antagonists (LABA-LAMA)

A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination

N/A

Inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) combination is c...

Status

Completed

Location

Papanikolaou Hospital of Thessaloniki

Start Date

2019-05-01

Trial ID

NCT03858348

Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients

N/A

This multicenter, retrospective-prospective, cohort study aims to evaluate ...

Status

Recruiting

Location

Santa Casa de Misericórdia de São Paulo

Start Date

2026-04-01

Trial ID

NCT07406048

Treatments Being Tested

BDP/FF/GB (100ug/6ug/12.5ug)

Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD

This randomized controlled trial aims to evaluate the effectiveness of acup...

Status

Active Not Recruiting

Location

Istanbul Medeniyet University Faculty of Medicine

Start Date

2024-11-15

Trial ID

NCT07058259

Treatments Being Tested

Acupuncture Standard COPD Pharmacological Therapy (LAMA + LABA or LAMA + LABA + ICS)

Air Pollution and Inhaled Corticosteroids in COPD

PHASE4

Studies have shown that people with chronic obstructive pulmonary disease (...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2025-04-01

Trial ID

NCT06552364

Treatments Being Tested

LABA+LAMA LABA+LAMA+ICS Filtered Air Diesel Exhaust

Previous Next